150 related articles for article (PubMed ID: 20075620)
41. Effect of
Kweon B; Han YH; Kee JY; Mun JG; Jeon HD; Yoon DH; Choi BM; Hong SH
Molecules; 2020 Apr; 25(9):. PubMed ID: 32349276
[TBL] [Abstract][Full Text] [Related]
42. Anti-Inflammatory Effect of Angelica gigas via Heme Oxygenase (HO)-1 Expression.
Cho JH; Kwon JE; Cho Y; Kim I; Kang SC
Nutrients; 2015 Jun; 7(6):4862-74. PubMed ID: 26083119
[TBL] [Abstract][Full Text] [Related]
43. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
Jung MH; Lee SH; Ahn EM; Lee YM
Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
[TBL] [Abstract][Full Text] [Related]
44. Chemometric classification of morphologically similar Umbelliferae medicinal herbs by DART-TOF-MS fingerprint.
Lee SM; Kim HJ; Jang YP
Phytochem Anal; 2012; 23(5):508-12. PubMed ID: 22271502
[TBL] [Abstract][Full Text] [Related]
45. Decursinol angelate: a cytotoxic and protein kinase C activating agent from the root of Angelica gigas.
Ahn KS; Sim WS; Lee IK; Seu YB; Kim IH
Planta Med; 1997 Aug; 63(4):360-1. PubMed ID: 9270380
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics and disposition of the novel dopamine agonist Z-7760 in rat after intravenous and oral administration.
Bollard M; Caldwell J; Taylor GW; Strolin-Benedetti M; Semeraro C
Xenobiotica; 2000 Oct; 30(10):983-91. PubMed ID: 11315106
[TBL] [Abstract][Full Text] [Related]
47. Interception Targets of
Tang SN; Jiang P; Kim S; Zhang J; Jiang C; Lü J
Cancer Prev Res (Phila); 2021 Jun; 14(6):635-648. PubMed ID: 33648943
[TBL] [Abstract][Full Text] [Related]
48. Absorption, distribution, metabolism and excretion of intravenously and orally administered tetrabromobisphenol A [2,3-dibromopropyl ether] in male Fischer-344 rats.
Knudsen GA; Jacobs LM; Kuester RK; Sipes IG
Toxicology; 2007 Jul; 237(1-3):158-167. PubMed ID: 17582672
[TBL] [Abstract][Full Text] [Related]
49. Decursin in Angelica gigas Nakai (AGN) Enhances Doxorubicin Chemosensitivity in NCI/ADR-RES Ovarian Cancer Cells via Inhibition of P-glycoprotein Expression.
Choi HS; Cho SG; Kim MK; Kim MS; Moon SH; Kim IH; Ko SG
Phytother Res; 2016 Dec; 30(12):2020-2026. PubMed ID: 27605402
[TBL] [Abstract][Full Text] [Related]
50. Intestinal handling of mercury in the rat: implications of intestinal secretion of inorganic mercury following biliary ligation or cannulation.
Zalups RK
J Toxicol Environ Health A; 1998 Apr; 53(8):615-36. PubMed ID: 9572160
[TBL] [Abstract][Full Text] [Related]
51. Decursinol from Angelica gigas Nakai enhances endometrial receptivity during implantation.
Kim SE; Lee JE; Han YH; Lee SI; Kim DK; Park SR; Yu SL; Kang J
BMC Complement Med Ther; 2020 Feb; 20(1):36. PubMed ID: 32024510
[TBL] [Abstract][Full Text] [Related]
52. Platelet anti-aggregatory effects of coumarins from the roots of Angelica genuflexa and A. gigas.
Lee YY; Lee S; Jin JL; Yun-Choi HS
Arch Pharm Res; 2003 Sep; 26(9):723-6. PubMed ID: 14560920
[TBL] [Abstract][Full Text] [Related]
53. Development and validation of an ultra-performance convergence chromatography method for the quality control of Angelica gigas Nakai.
Kim HS; Chun JM; Kwon BI; Lee AR; Kim HK; Lee AY
J Sep Sci; 2016 Oct; 39(20):4035-4041. PubMed ID: 27510737
[TBL] [Abstract][Full Text] [Related]
54. Chemopreventive Effects of Korean Angelica versus Its Major Pyranocoumarins on Two Lineages of Transgenic Adenocarcinoma of Mouse Prostate Carcinogenesis.
Tang SN; Zhang J; Wu W; Jiang P; Puppala M; Zhang Y; Xing C; Kim SH; Jiang C; Lü J
Cancer Prev Res (Phila); 2015 Sep; 8(9):835-44. PubMed ID: 26116406
[TBL] [Abstract][Full Text] [Related]
55. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
[TBL] [Abstract][Full Text] [Related]
56. Disposition of salmeterol xinafoate in laboratory animals and humans.
Manchee GR; Barrow A; Kulkarni S; Palmer E; Oxford J; Colthup PV; Maconochie JG; Tarbit MH
Drug Metab Dispos; 1993; 21(6):1022-8. PubMed ID: 7905380
[TBL] [Abstract][Full Text] [Related]
57. Decursin and decursinol angelate: molecular mechanism and therapeutic potential in inflammatory diseases.
Shehzad A; Parveen S; Qureshi M; Subhan F; Lee YS
Inflamm Res; 2018 Mar; 67(3):209-218. PubMed ID: 29134229
[TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetics of TDP223206 following intravenous and oral administration to intact rats and intravenous administration to bile duct-cannulated rats.
Chen Y; Cheng D; Marugan JJ; Manthey C; Tomczuk B; Huebert N
Biopharm Drug Dispos; 2008 May; 29(4):219-30. PubMed ID: 18260095
[TBL] [Abstract][Full Text] [Related]
59. Absorption, protein binding, pharmacokinetics and excretion of the anti-ischemic and anti-hypertensive arylpiperazine derivative CDRI-93/478 in rats.
Lal J; Gupta RC
Arzneimittelforschung; 2008; 58(2):62-70. PubMed ID: 18412019
[TBL] [Abstract][Full Text] [Related]
60.
Lü J; Jiang C; Schell TD; Joshi M; Raman JD; Xing C
Am J Chin Med; 2022; 50(6):1475-1527. PubMed ID: 35876033
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
